These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21268912)

  • 1. [Serum biomarkers in idiopathic pulmonary fibrosis].
    Chudzicka A
    Pol Merkur Lekarski; 2010 Nov; 29(173):291-5. PubMed ID: 21268912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum biomarkers in idiopathic pulmonary fibrosis].
    Ziora D
    Pneumonol Alergol Pol; 2007; 75(3):268-72. PubMed ID: 17966103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of serum clara cell 16-kDa (CC16) levels as a potential indicator of active pulmonary fibrosis in systemic sclerosis.
    Hasegawa M; Fujimoto M; Hamaguchi Y; Matsushita T; Inoue K; Sato S; Takehara K
    J Rheumatol; 2011 May; 38(5):877-84. PubMed ID: 21239758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The examinations for diffuse lung diseases].
    Otake K; Suwabe A; Tominaga M
    Rinsho Byori; 2000 Dec; 48(12):1112-7. PubMed ID: 11215419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis.
    Yokoyama A; Kondo K; Nakajima M; Matsushima T; Takahashi T; Nishimura M; Bando M; Sugiyama Y; Totani Y; Ishizaki T; Ichiyasu H; Suga M; Hamada H; Kohno N
    Respirology; 2006 Mar; 11(2):164-8. PubMed ID: 16548901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D.
    Takahashi H; Shiratori M; Kanai A; Chiba H; Kuroki Y; Abe S
    Respirology; 2006 Jan; 11 Suppl():S51-4. PubMed ID: 16423272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of serum surfactant protein-D (SP-D) level in patients with pulmonary tuberculosis].
    Kondo A; Oketani N; Maruyama M; Taguchi Y; Yamaguchi Y; Miyao H; Mashima I; Oono M; Wada K; Tsuchiya T; Takahashi H; Abe S
    Kekkaku; 1998 Oct; 73(10):585-90. PubMed ID: 9844346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis.
    Greene KE; King TE; Kuroki Y; Bucher-Bartelson B; Hunninghake GW; Newman LS; Nagae H; Mason RJ
    Eur Respir J; 2002 Mar; 19(3):439-46. PubMed ID: 11936520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent.
    Takahashi H; Fujishima T; Koba H; Murakami S; Kurokawa K; Shibuya Y; Shiratori M; Kuroki Y; Abe S
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):1109-14. PubMed ID: 10988138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].
    Kohno N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
    Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
    Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases.
    Satoh H; Kurishima K; Ishikawa H; Ohtsuka M
    J Intern Med; 2006 Nov; 260(5):429-34. PubMed ID: 17040248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
    Asano Y; Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Tamaki K
    Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant appearance of lung surfactant protein A in sera of patients with idiopathic pulmonary fibrosis and its clinical significance.
    Honda Y; Kuroki Y; Shijubo N; Fujishima T; Takahashi H; Hosoda K; Akino T; Abe S
    Respiration; 1995; 62(2):64-9. PubMed ID: 7784711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Values For Club Cell Secretory Protein (CC16) in Serum of Patients of Combined Pulmonary Fibrosis and Emphysema.
    Kokuho N; Ishii T; Kamio K; Hayashi H; Kurahara M; Hattori K; Motegi T; Azuma A; Gemma A; Kida K
    COPD; 2015 Aug; 12(4):347-54. PubMed ID: 25244495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis.
    Kodera M; Hasegawa M; Komura K; Yanaba K; Takehara K; Sato S
    Arthritis Rheum; 2005 Sep; 52(9):2889-96. PubMed ID: 16142750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating bronchoepithelial cells expressing mRNA for surfactant protein A in patients with pulmonary fibrosis.
    Dohmoto K; Hojo S; Fujita J; Kamei T; Ueda Y; Miyawaki H; Bandoh S; Okada H; Takahara J
    Respir Med; 2000 May; 94(5):475-81. PubMed ID: 10868711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype of regenerative epithelium in idiopathic interstitial pneumonias.
    Hinata N; Takemura T; Ikushima S; Yanagawa T; Ando T; Okada J; Oritsu M; Koike M
    J Med Dent Sci; 2003 Sep; 50(3):213-24. PubMed ID: 15074359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive biomarkers in pulmonary fibrosis.
    Prasse A; Müller-Quernheim J
    Respirology; 2009 Aug; 14(6):788-95. PubMed ID: 19703061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of antiinflammatory therapy in patients with interstitial lung diseases using re-assay of biomarker mucin 3EG5].
    Avdeeva OE; Lebedin IuS; Avdeev SN; Chuchalin AG
    Ter Arkh; 2000; 72(3):28-32. PubMed ID: 10776650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.